We are monitoring the impact of COVID-19 on MEA Active Implantable Medical Devices Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4856
Share on
Share on

Middle East & Africa Active Implantable Medical Devices Market Research Report – Segmented By Product & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4856
Pages: 145

MEA Active Implantable Medical Devices Market Size (2021 to 2026)

The size of the Active Implantable Medical Devices Market in the Middle East & Africa is valued at USD 2.07 billion in 2021. It is expected to reach USD 2.91 billion by 2026, to grow at a CAGR of 7.06% during the forecast period.

The increase in the geriatric population is one of the important drivers for the growth of the market. The number of people aged 60 and over is expected to increase from 535 million in 2012 to nearly 1.7 billion in 2050, or around 18% of the world's population. In addition, the increase in chronic diseases coupled with advancements in active implantable medical devices is expected to drive the growth of the regional active implantable medical devices market, which greatly benefits from the increasing prevalence of various chronic diseases, such as cardiovascular and neurological disorders. Consistent product launches and a streamlined approval process also significantly support the growth of this market. The escalating investments and funds to upgrade more latest technological products, the increasing use, and applications of neurostimulators, and the favorable reimbursement scenario of ENT procedures in developed regions are likely to accelerate the active market growth for implantable medical devices around the world. The forecast period 2020-2025. On the other hand, the emerging market offering significant growth will further drive several opportunities, which will lead to the growth of the MEA active implantable medical device market during the forecast period mentioned above.

Problems with using active implantable medical devices, such as device failure and cybersecurity concerns, could hamper the market growth in the near future. The exceeded cost of implants and a recovery scenario unfavorable will likely hamper the development of the active implantable medical devices market during the forecast, as mentioned earlier period. The shortage of qualified professionals and the strong pressure on companies will be a major challenge for the active market for implantable medical devices. Also, regional brands' presence and availability and the challenges they face due to strong or weak competition from local and national brands.

This research report on the MEA Active Implantable Medical Devices Market report has been segmented and sub-segmented into the following categories:

By Product: 

  • Implantable Cardioverter Defibrillators
    • Transvenous Implantable Cardioverter Defibrillators
      • Biventricular Implantable Cardioverter Defibrillators (ICDs)/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
      • Dual-Chamber Implantable Cardioverter Defibrillators
      • Single-Chamber Implantable Cardioverter Defibrillators
    • Subcutaneous Implantable Cardioverter Defibrillator
  • Implantable Cardiac Pacemakers
  • Ventricular Assist Devices
  • Implantable Heart Monitors/Insertable Loop Recorders
  • Neurostimulators
    • Spinal Cord Stimulators
    • Deep Brain Stimulators
    • Sacral Nerve Stimulators
    • Vagus Nerve Stimulators
    • Gastric Electrical Stimulators
  • Implantable Hearing Devices
    • Active Hearing Implants
    • Passive Hearing Implants

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, MEA dominates the active implantable medical device market due to its high accessibility to cutting edge technologies, growing development of innovative and technologically advanced products, and increasing healthcare spending in the region, while the Asia Pacific is expected to grow at the same time highest growth rate in the forecast period from 2020 to 2025 due to the increasing incidence of chronic diseases, increased health spending, health reforms for infrastructure development, increasing demand for advanced technologies to develop advanced products and less stringent regulations. MEA has dominated a significant share of the region implantable and survival device market. The greater participation of the MEA is mainly attributed to the geriatric population's growth, the increase in the prevalence of cardiovascular and neurological diseases, the high accessibility to advanced technologies, the increase in the development of innovative and technologically advances, and increased health spending in the region.

Noteworthy companies leading the Middle East & Africa Active Implantable Medical Devices Market Profiled in the Report are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC., Cochlear Limited, MED-EL, Sonova Holding AG, William Demant Holding A/S, and Nurotron Biotechnology Co. Ltd.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Implantable Cardioverter Defibrillators                      

                                                5.1.2.1 Transvenous Implantable Cardioverter Defibrillators        

                                                                5.1.2.1.1 Biventricular Implantable Cardioverter Defibrillators (ICDs)/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)

                                                                5.1.2.1.2 Dual-Chamber Implantable Cardioverter Defibrillators

                                                                5.1.2.1.3 Single-Chamber Implantable Cardioverter Defibrillators

                                                5.1.2.2 Subcutaneous Implantable Cardioverter Defibrillator       

                                5.1.3 Implantable Cardiac Pacemakers                   

                                5.1.4 Ventricular Assist Devices                 

                                5.1.5 Implantable Heart Monitors/Insertable Loop Recorders                     

                                5.1.6 Neurostimulators                 

                                                5.1.6.1 Spinal Cord Stimulators  

                                                5.1.6.2 Deep Brain Stimulators  

                                                5.1.6.3 Sacral Nerve Stimulators               

                                                5.1.6.4 Vagus Nerve Stimulators               

                                                5.1.6.5 Gastric Electrical Stimulators        

                                5.1.7 Implantable Hearing Devices                           

                                                5.1.7.1 Active Hearing Implants 

                                                5.1.7.2 Passive Hearing Implants              

                                5.1.5  Y-o-Y Growth Analysis, By Product                              

                                5.1.6  Market Attractiveness Analysis, By Product                            

                                5.1.7  Market Share Analysis, By Product                              

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                6.2 Middle-East                                                

                6.3 Africa                                            

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Medtronic plc                                            

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Abbott Laboratories                                               

                8.3 Boston Scientific Corporation                                             

                8.4 BIOTRONIK SE & Co. KG                                        

                8.5 LivaNova PLC.                                            

                8.6 Cochlear Limited                                      

                8.7 MED-EL                                        

                8.8 Sonova Holding AG                                 

                8.9 William Demant Holding A/S                                               

                8.10 Nurotron Biotechnology Co. Ltd.                                    

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of Product along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the region-wise market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Active Implantable Medical Devices Market, By Product, From 2021 to 2026 (USD Million)
  2. Middle East & Africa Implantable Cardioverter Defibrillators Market, By Region, From 2021 to 2026 (USD Million)
  3. Middle East & Africa Cardiac Pacemaker Market, By Region, From 2021 to 2026 (USD Million)
  4. Middle East & Africa Ventricular Assist Device Market, By Region, From 2021 to 2026 (USD Million)
  5. Middle East & Africa Neurostimulator Market, By Region, From 2021 to 2026 (USD Million)
  6. Middle East & Africa Implantable Hearing Devices Market, By Region, From 2021 to 2026 (USD Million)
  7. Middle East Active Implantable Medical Devices Market, By Product, From 2021 to 2026 (USD Million)
  8. Africa Active Implantable Medical Devices Market, By Product, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample